Identification of Novel Imidazo[1,2-a]pyridine Inhibitors Targeting M. tuberculosis QcrB
Open Access
- 31 December 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (12), e52951
- https://doi.org/10.1371/journal.pone.0052951
Abstract
Mycobacterium tuberculosis is a major human pathogen and the causative agent for the pulmonary disease, tuberculosis (TB). Current treatment programs to combat TB are under threat due to the emergence of multi-drug and extensively-drug resistant TB. Through the use of high throughput whole cell screening of an extensive compound library a number of imidazo[1,2-a]pyridine (IP) compounds were obtained as potent lead molecules active against M. tuberculosis and Mycobacterium bovis BCG. The IP inhibitors (1–4) demonstrated minimum inhibitory concentrations (MICs) in the range of 0.03 to 5 µM against a panel of M. tuberculosis strains. M. bovis BCG spontaneous resistant mutants were generated against IP 1, 3, and 4 at 5× MIC and subsequent whole genome sequencing identified a single nucleotide polymorphism 937ACC>937GCC (T313A) in qcrB, which encodes the b subunit of the electron transport ubiquinol cytochrome C reductase. This mutation also conferred cross-resistance against IP 1, 3 and 4 demonstrating a common target. Gene dosage experiments confirmed M. bovis BCG QcrB as the target where over-expression in M. bovis BCG led to an increase in MIC from 0.5 to >8 µM for IP 3. An acute murine model of TB infection established bacteriostatic activity of the IP series, which await further detailed characterization.This publication has 53 references indexed in Scilit:
- Screening a library of 1600 adamantyl ureas for anti-Mycobacterium tuberculosis activity in vitro and for better physical chemical properties for bioavailabilityBioorganic & Medicinal Chemistry, 2012
- A High-Throughput Screen To Identify Inhibitors of ATP Homeostasis in Non-replicating Mycobacterium tuberculosisACS Chemical Biology, 2012
- MmpL Genes Are Associated with Mycolic Acid Metabolism in Mycobacteria and CorynebacteriaCell Chemical Biology, 2012
- Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membraneNature Chemical Biology, 2012
- High throughput screening of a library based on kinase inhibitor scaffolds against Mycobacterium tuberculosis H37RvTuberculosis, 2012
- Advent of Imidazo[1,2-a]pyridine-3-carboxamides with Potent Multi- and Extended Drug Resistant Antituberculosis ActivityACS Medicinal Chemistry Letters, 2011
- Antituberculosis activity of the molecular libraries screening center network libraryTuberculosis, 2009
- High-throughput screening for inhibitors of Mycobacterium tuberculosis H37RvTuberculosis, 2009
- The Q-cycle reviewed: How well does a monomeric mechanism of the bc1 complex account for the function of a dimeric complex?Biochimica et Biophysica Acta (BBA) - Bioenergetics, 2008
- Genome plasticity of BCG and impact on vaccine efficacyProceedings of the National Academy of Sciences of the United States of America, 2007